Remove Avalon Remove Capital Remove Invest Remove Technology
article thumbnail

Avalon Ventures Gets Commitments Of $103M In New, $300M Fund

socalTECH

La Jolla-based venture capital investor Avalon Ventures has just received a $103M commitment to a new, $300M fund, according to a regulatory filing by the firm. Avalon invests in both life sciences and technology companies, and invests in seed an dearly stage companies. READ MORE>>.

Avalon 100
article thumbnail

Avalon Ventures Closes $200M Fund

socalTECH

San Diego-based Avalon Ventures , a venture capital firm focused on early stage high tech, digital media, and life sciences firms, said today that it has closed on $200M in capital commitments for its latest fund. Avalon said that the fund, Avalon Ventures IX, LP, is the ninth and largest fund for the company.

Avalon 140
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Avelas Biosciences Finds $7.4M

socalTECH

The second tranche of the company''s Series B came from investors Avalon Ventures, Torrey Pines Investment and WuXi PharmaTech Investments. The technology behind the Avelas product is based on research conducted at UC San Diego. in a Series B funding. READ MORE>>.

Avalon 147
article thumbnail

Avelas Biosciences Raises $6.85M

socalTECH

San Diego-based Avelas Biosciences announced today that it has raised $6.85M in a Series B funding round, for the company''s technology for illuminating cancer cells. The company said the funding came from Avalon Ventures, and also included Torrey Pines Investment, WuXi AppTec, and an additional, un-named investor. READ MORE>>.

Avalon 138
article thumbnail

Southern California Bucks VC Trend, As Firms Raise $924.13M In Q1

socalTECH

The latest numbers from the MoneyTree Report from PricewaterhouseCoopers, The National Venture Capital Association, and Thomson Reuters have tallied up just under a billion dollars in venture capital investments in the Southern California region in Q1 of this year, a very significant uptick from Q2 of 2011. in 13 deals.

article thumbnail

Southern California Firms Raise $738M In Q4 2011

socalTECH

The latest numbers from the PricewaterhouseCoopers/National Venture capital Association MoneyTree survey, which is based on data from Thomson Reuters, tallies $738.34M invested in Southern California in Q4 of 2011. raised in Q4 of 2010, and up from the $652M invested in the region last quarter. The amount is up from $528.0M

article thumbnail

Avelas Bio Raises $20M to Push Cancer-Illuminating Biologic Agent

Xconomy

Pharmstandard International, the Luxembourg-based investment arm of the Russian pharmaceutical giant Pharmstandard (and a first-time investor in Avelas), led the round. It was joined by two other new backers, Ervington Investments and Alexandria Venture Investments, and previous investors WuXi Healthcare Ventures, Bregua Corp.,

Avalon 40